# Safety and Efficacy Study of Angiotech Central Venous Catheter to Prevent Bacterial Catheter Colonization

> **NCT00288418** · PHASE3 · COMPLETED · sponsor: **Angiotech Pharmaceuticals** · enrollment: 960 (actual)

## Conditions studied

- Bacterial Infections

## Interventions

- **DEVICE:** Central Venous Catheter

## Key facts

- **NCT ID:** NCT00288418
- **Lead sponsor:** Angiotech Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 960 (ACTUAL)
- **Last updated:** 2013-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00288418

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00288418, "Safety and Efficacy Study of Angiotech Central Venous Catheter to Prevent Bacterial Catheter Colonization". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00288418. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*